scispace - formally typeset
L

Livius Penter

Researcher at Charité

Publications -  23
Citations -  1293

Livius Penter is an academic researcher from Charité. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 7, co-authored 12 publications receiving 904 citations. Previous affiliations of Livius Penter include Harvard University & Humboldt University of Berlin.

Papers
More filters
Journal ArticleDOI

Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

Andrea Cossarizza, +462 more
TL;DR: These guidelines are a consensus work of a considerable number of members of the immunology and flow cytometry community providing the theory and key practical aspects offlow cytometry enabling immunologists to avoid the common errors that often undermine immunological data.
Journal ArticleDOI

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

TL;DR: Ruxolitinib may constitute a promising new treatment option for SR-aGVHD and SR-cGVHD that should be validated in a prospective trial.
Journal ArticleDOI

Localization-associated immune phenotypes of clonally expanded tumor-infiltrating T cells and distribution of their target antigens in rectal cancer.

TL;DR: rectal cancer is infiltrated with expanded distinct-phenotype T cell clones that either i) predominantly infiltrate the tumor, ii) predominantly infiltrated the unaffected mucosa, or iii) overlap between tumor, unaffected mucoso, and peripheral blood.
Journal ArticleDOI

FACS single cell index sorting is highly reliable and determines immune phenotypes of clonally expanded T cells.

TL;DR: The error rate of index sorting is experimentally determined and the technology is combined with T cell receptor sequencing to identify clonal T-cell expansion in aplastic anemia bone marrow as an example.
Journal ArticleDOI

Clonal Expansion and Interrelatedness of Distinct B-Lineage Compartments in Multiple Myeloma Bone Marrow.

TL;DR: The phenotypic range of multiple myeloma cells in the bone marrow is not confined to aberrant-phenotype plasma cells but extends to low frequencies of normal-phenotypes B cells, in line with the recently reported success of B cell–targeting cellular therapies in some patients.